BioSphere Medical Inc.
1050 Hingham St
Rockland
MA
02370
United States
(781) 681-7900
Product(s):
Develops embolic therapies for uterine fibroids
Employees:
47 (75)
Established:
1993
Ownership:
Public
Exchange:
NSDQ
symbol:
BSMD
2004 Revenue:
$14,158,000
2005 Revenue:
$18,484,000
2006 Revenue:
$22,891,000
2007 Revenue:
$26,900,000
2008 Revenue:
$29,258,000
Yahoo Quotes:
CEO:
Richard J. Faleschini Management:
Martin J. Joyce, EVP-Finance & Admin., CFO
Melodie R. Domurad, VP-Regulatory, Medical Affairs & Quality systems
Willard W. Hennemann, VP-New Product & Business Development
Peter Sutcliffe, VP-Manufacturing
Joel B. Weinstein, VP-Global Marketing & Sales
Biosphere Medical Inc.
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
